会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Thiazolo[5,4-h]quinoline compounds useful as anti-allergy agents
    • 噻唑并[5,4-h]喹啉化合物可用作抗过敏剂
    • US4698346A
    • 1987-10-06
    • US889021
    • 1986-07-24
    • John H. MusserRichard E. Brown
    • John H. MusserRichard E. Brown
    • C07D215/28C07D498/04A61K31/425C07D513/04
    • C07D215/28
    • New quinoline compound, and the corresponding 1,2-; 1,3-; and 1,4-benzodiazines, the quinoline compounds being of the formula: ##STR1## and salts thereof, wherein R.sub.1 and R.sub.2 are independently hydrogen, lower alkyl, halo, trifluoromethyl, amino, lower alkyl amino, lower acylamino, cyano, aryl, aryl/lower alkylene, nitro, lower alkynyl, lower alkenyl, lower alkyl sulfinyl, lower alkyl sulfonyl, lower alkoxycarbonyl, carboxyl, lower alkoxy, lower alkanoyl, or lower alkenoyl,Y is oxygen, sulfur, nitrogen or R.sub.3 N wherein R.sub.3 is hydrogen, lower alkyl, alkenyl, alkynyl, aryl, aralkyl, acyl, aminoalkyl, or carboxyalkyl,Z is oxygen, sulfur or nitrogen,X is cyano, carbalkoxyl, carboxyl, formyloximino, tetrazolyl, carbalkoxyalkyl or carboxyalkyl, andm is 0 or 1, are useful as medicinals, especially for treatment of asthma, and/or as intermediates in the preparation of compounds useful for treating asthma.
    • 新喹啉化合物及相应的1,2-; 1,3- 和1,4-苯并二嗪,喹啉化合物具有下式:其中R1和R2独立地是氢,低级烷基,卤素,三氟甲基,氨基,低级烷基氨基,低级酰氨基,氰基,芳基 ,芳基/低级亚烷基,硝基,低级炔基,低级烯基,低级烷基亚磺酰基,低级烷基磺酰基,低级烷酰基,羧基,低级烷氧基,低级烷酰基或低级烯酰基,Y为氧,硫,氮或R 3 N,其中R 3为氢 低级烷基,烯基,炔基,芳基,芳烷基,酰基,氨基烷基或羧基烷基,Z是氧,硫或氮,X是氰基,烷氧羰基,羧基,甲酰肟基,四唑基,烷氧基烷基或羧基烷基,m是0或1, 可用作药物,特别是用于治疗哮喘,和/或作为制备用于治疗哮喘的化合物的中间体。
    • 2. 发明授权
    • Certain 1,3-oxazolo[4,5H]quinolines useful as anti-allergy agents
    • 某些用作抗过敏剂的1,3-恶唑并[4,5H]喹啉
    • US4522947A
    • 1985-06-11
    • US476673
    • 1983-03-18
    • John H. MusserRichard E. Brown
    • John H. MusserRichard E. Brown
    • C07D215/28C07D498/04A61K31/47
    • C07D215/28
    • New quinoline compound, and the corresponding 1,2-; 1,3-; and 1,4-benzodiazines, the quinoline compounds being of the formula: ##STR1## and salts thereof, wherein R.sub.1 and R.sub.2 are independently hydrogen, lower alkyl, halo, trifluoromethyl, amino, lower alkyl amino, lower acylamino, cyano, aryl, aryl/lower alkylene, nitro, lower alkynyl, lower alkenyl, lower alkyl sulfinyl, lower alkyl sulfonyl, lower alkoxycarbonyl, carboxyl, lower alkoxy, lower alkanoyl, or lower alkenoyl,Y is oxygen, sulfur, nitrogen or R.sub.3 N wherein R.sub.3 is hydrogen, lower alkyl, alkenyl, alkynyl, aryl, aralkyl, acyl, aminoalkyl, or carboxyalkyl,Z is oxygen, sulfur or nitrogen,X is cyano, carbalkoxyl, carboxyl, formyloximino, tetrazolyl, carbalkoxyalkyl or carboxyalkyl, andm is 0 or 1, are useful as medicinals, especially for treatment of asthma, and/or as intermediates in the preparation of compounds useful for treating asthma.
    • 新喹啉化合物及相应的1,2-; 1,3- 和1,4-苯并二嗪,喹啉化合物具有下式:其中R1和R2独立地是氢,低级烷基,卤素,三氟甲基,氨基,低级烷基氨基,低级酰氨基,氰基,芳基 ,芳基/低级亚烷基,硝基,低级炔基,低级烯基,低级烷基亚磺酰基,低级烷基磺酰基,低级烷酰基,羧基,低级烷氧基,低级烷酰基或低级烯酰基,Y为氧,硫,氮或R 3 N,其中R 3为氢 低级烷基,烯基,炔基,芳基,芳烷基,酰基,氨基烷基或羧基烷基,Z是氧,硫或氮,X是氰基,烷氧羰基,羧基,甲酰肟基,四唑基,烷氧基烷基或羧基烷基,m是0或1, 可用作药物,特别是用于治疗哮喘,和/或作为制备用于治疗哮喘的化合物的中间体。
    • 3. 发明授权
    • Imidazo quinoline compounds useful as anti-allergy agents
    • 咪唑喹啉化合物可用作抗过敏剂
    • US4656281A
    • 1987-04-07
    • US731689
    • 1985-05-08
    • John H. MusserRichard E. Brown
    • John H. MusserRichard E. Brown
    • C07D215/28C07D498/04C07D471/04
    • C07D215/28
    • The quinoline compounds being of the formula: ##STR1## and salts thereof, wherein R.sub.1 and R.sub.2 are independently hydrogen, lower alkyl, halo, trifluoromethyl, amino, lower alkyl amino, lower acylamino, cyano, aryl, aryl/lower alkylene, nitro, lower alkynyl, lower alkenyl, lower alkyl sulfinyl, lower alkyl sulfonyl, lower alkoxycarbonyl, carboxyl, lower alkoxy, lower alkanoyl, or lower alkenoyl,Y is nitrogen or R.sub.3 N wherein R.sub.3 is hydrogen, lower alkyl, alkenyl, alkynyl, aryl aralkyl, acyl, aminoalkyl, or carboxyalkyl,Z is nitrogen,X is cyano, carbalkoxyl, carboxyl, formyloximino, tetrazolyl, carbalkoxyalkyl or carboxyalkyl, andm is 0 or 1, are useful as medicinals, especially for treatment of asthma, and/or intermediates in the preparation of compounds useful for treating asthma.
    • 喹啉化合物具有下式:其中R1和R2独立地是氢,低级烷基,卤素,三氟甲基,氨基,低级烷基氨基,低级酰氨基,氰基,芳基,芳基/低级亚烷基,硝基 低级炔基,低级烯基,低级烷基亚磺酰基,低级烷基磺酰基,低级烷氧基羰基,羧基,低级烷氧基,低级烷酰基或低级烯酰基,Y为氮或R3N,其中R3为氢,低级烷基,烯基,炔基,芳基芳烷基, 酰基,氨基烷基或羧基烷基,Z是氮,X是氰基,甲酰氧基,羧基,甲酰肟基,四唑基,烷氧基烷基或羧基烷基,m是0或1,可用作药物,特别是用于治疗哮喘和/ 可用于治疗哮喘的化合物的制备。
    • 4. 发明授权
    • 2-Oxo-1,3-oxazolo[4,5-h] quinolines useful as anti-allergy agents
    • 可用作抗过敏剂的2-氧代-1,3-恶唑并[4,5-h]喹啉
    • US4563463A
    • 1986-01-07
    • US667667
    • 1984-11-02
    • John H. MusserRichard E. Brown
    • John H. MusserRichard E. Brown
    • C07D215/28C07D498/04A61K31/47
    • C07D215/28
    • New quinoline compound, and the corresponding 1,2-; 1,3-; and 1,4-benzodiazines, the quinoline compounds being of the formulae: ##STR1## and salts thereof, wherein R is hydrogen, acyl, carboethoxy,(3-methoxyphen)acetyl,(2-phenyl)propionyl, dimethylcarbamoyl or methyl,R.sub.1 and R.sub.2 are independently hydrogen, lower alkyl, halo, trifluoromethyl, amino, lower alkyl amino, lower acylamino, cyano, aryl, aryl/lower alkylene, nitro, lower alkynyl, lower alkenyl, lower alkyl sulfinyl, lower alkyl sulfonyl, lower alkoxycarbonyl, carboxyl, lower alkoxy, lower alkanoyl, or lower alkenoyl,Y is oxygen, sulfur, nitrogen or R.sub.3 N wherein R.sub.3 is hydrogen, lower alkyl, alkenyl, alkynyl, aryl, aralkyl, acyl, aminoalkyl, or carboxyalkyl,Z is oxygen, sulfur or nitrogen,X is cyano, carbalkoxy, carboxyl, formyloximino, tetrazolyl, carbalkoxyalkyl or carboxyalkyl, andm is 0 or 1, are useful as medicinals, especially for treatment of asthma, and/or as intermediates in the preparation of compounds useful for treating asthma.
    • 新喹啉化合物及相应的1,2-; 1,3- 其中R为氢,酰基,乙酰乙氧基,(3-甲氧基苯基)乙酰基,(2-苯基)丙酰基,二甲基氨基甲酰基或甲基,R 1,R 2, 氰基,芳基,芳基/低级亚烷基,硝基,低级炔基,低级烯基,低级烷基亚磺酰基,低级烷基磺酰基,低级烷氧基羰基,低级烷基氨基,低级烷基氨基, 羧基,低级烷氧基,低级烷酰基或低级烯酰基,Y是氧,硫,氮或R3N,其中R3是氢,低级烷基,烯基,炔基,芳基,芳烷基,酰基,氨基烷基或羧基烷基,Z是氧,硫或 氮,X为氰基,烷氧羰基,羧基,甲酰肟基,四唑基,碳烷氧基烷基或羧基烷基,m为0或1,可用作药物,特别是用于治疗哮喘,和/或作为制备用于治疗哮喘的化合物的中间体 。
    • 9. 发明授权
    • Substituted benzopyrano [3,4-c]pyridines for the treatment of bronchial
asthma
    • 取代的苯并吡喃并[8,3-c {9吡啶用于治疗支气管哮喘
    • US3984546A
    • 1976-10-05
    • US622547
    • 1975-10-15
    • Richard E. BrownJohn Shavel, Jr.
    • Richard E. BrownJohn Shavel, Jr.
    • A61K31/535A61K31/54A61K31/44A61K31/445
    • C07D491/052A61K31/535A61K31/54Y10S514/826
    • Substituted benzopyrano[3,4-c]pyridines having the following structural formula are disclosed: ##SPC1##In the above formula, R.sub.1 and R.sub.2 are hydrogen, a hydroxyl group or a lower alkoxyl group of from 1 to 6 carbon atoms; and X is an oxygen atom, a sulfur atom, a methylene group or a nitrogen atom substituted by hydrogen, a lower alkyl group of from 1 to 6 carbon atoms or a lower alkanoyl group of from 1 to 6 carbon atoms. The compounds of this invention are prepared by reacting an R.sub.1, R.sub.2 -substituted phenol with a 3-carbethoxy-4-piperidone in the presence of an acid catalyst to give an intermediate R.sub.1, R.sub.2 -substituted benzopyrano[3,4-c]pyridine. N-aminoalkylbenzopyrano[3,4-c]pyridines are obtained by treating the benzopyrano[3,4-c]pyridine with an appropriately substituted alkyl halide. The compounds of this invention are useful as bronchodilators for the treatment of bronchial asthma.
    • 公开了具有以下结构式的取代的苯并吡喃并[3,4-c]吡啶:在上式中,R 1和R 2是氢,羟基或具有1至6个碳原子的低级烷氧基; X为氧原子,硫原子,亚甲基或被氢取代的氮原子,1〜6个碳原子的低级烷基或1〜6个碳原子的低级烷酰基。 本发明化合物是通过在酸催化剂存在下使R1,R2取代的苯酚与3-乙酯基-4-哌啶酮反应得到中间体R1,R2取代的苯并吡喃并[3,4-c]吡啶 。 通过用适当取代的烷基卤处理苯并吡喃并[3,4-c]吡啶得到N-氨基烷基苯并吡喃并[3,4-c]吡啶。 本发明的化合物可用作治疗支气管哮喘的支气管扩张剂。
    • 10. 发明授权
    • Benzopyrano(3,4-C)pyridine bronchodilators
    • 苯并吡喃(3,4-C)吡啶支气管扩张剂
    • US3961057A
    • 1976-06-01
    • US538424
    • 1975-01-03
    • Richard E. BrownJohn Shavel, Jr.
    • Richard E. BrownJohn Shavel, Jr.
    • A61K31/535
    • C07D491/052A61K31/535Y10S514/826
    • Substituted benzopyrano[3,4-c]pyridines having the following structural formula are disclosed: ##SPC1##In the above formula, R.sub.1 and R.sub.2 are hydrogen, a hydroxyl group or a lower alkoxyl group of from 1 to 6 carbon atoms; R.sub.3 is hydrogen or a lower alkyl group of from 1 to 6 carbon atoms and X is an oxygen atom, a sulfur atom, a methylene group or a nitrogen atom substituted by hydrogen, a lower alkyl group of from 1 to 6 carbon atoms or a lower alkanoyl group of from 1 to 6 carbon atoms. The compounds of this invention are prepared by reacting an R.sub.1, R.sub.2 -substituted phenol with a 3-carbethoxy-4-piperidone in the presence of an acid catalyst to give an intermediate R.sub.1, R.sub.2 -substituted benzopyrano[3,4-c]pyridine. N-aminoalkylbenzopyrano[3,4-c]pyridines are obtained by treating the benzopyrano[3,4-c]pyridine with an appropriately substituted alkyl halide. The compounds of this invention are useful as bronchodilators for the treatment of bronchial asthma.
    • 公开了具有以下结构式的取代的苯并吡喃并[3,4-c]吡啶:在上式中,R 1和R 2是氢,羟基或具有1至6个碳原子的低级烷氧基; R3是氢或1〜6个碳原子的低级烷基,X是氧原子,硫原子,亚甲基或被氢取代的氮原子,1〜6个碳原子的低级烷基或 1至6个碳原子的低级烷酰基。 本发明化合物是通过在酸催化剂存在下使R1,R2取代的苯酚与3-乙酯基-4-哌啶酮反应得到中间体R1,R2取代的苯并吡喃并[3,4-c]吡啶 。 通过用适当取代的烷基卤处理苯并吡喃并[3,4-c]吡啶得到N-氨基烷基苯并吡喃并[3,4-c]吡啶。 本发明的化合物可用作治疗支气管哮喘的支气管扩张剂。